Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Arkowitz David

SEC-identified person · CIK 1296999 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Ibiopharma, Inc. ibio Director filed 2024 - 2025
Yumanity Therapeutics, INC. YMTX Director filed 2019 - 2025
Seres Therapeutics, Inc. MCRB See Remarks filed 2021 - 2024
Spring Bank Pharmaceuticals, Inc. SBPH Director filed 2016 - 2023
Flexion Therapeutics Inc FLXN Chief Financial Officer filed 2018 - 2021
Amag Pharmaceuticals, INC. AVM EVP, Chief Financial Officer filed 2007 - 2011
Idenix Pharmaceuticals INC IDIX Chief Financial Officer filed 2006 - 2007

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.